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Abstract
Cardiorespiratory fitness (CRF) is not only an objective measure of habitual physical activity, but also a useful diagnostic and prognostic health
indicator for patients in clinical settings. Although compelling evidence has shown that CRF is a strong and independent predictor of all-cause and
cardiovascular disease mortality, the importance of CRF is often overlooked from a clinical perspective compared with other risk factors such as
hypertension, diabetes, smoking, or obesity. Several prospective studies indicate that CRF is at least as important as the traditional risk factors, and is
often more strongly associated with mortality. In addition, previous studies report that CRF appears to attenuate the increased risk of death associated
with obesity. Most individuals can improve their CRF through regular physical activity. Several biological mechanisms suggest that CRF improves insulin
sensitivity, blood lipid profile, body composition, inflammation, and blood pressure. Based on the evidence, health professionals should encourage their
patients to improve CRF through regular physical activity.
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Introduction
Cardiorespiratory ﬁtness (CRF) is a health-related compo-
nent of physical ﬁtness deﬁned as the ability of the circula-
tory, respiratory, and muscular systems to supply oxygen
during sustained physical activity. CRF is usually expressed
in metabolic equivalents (METs) or maximal oxygen uptake
(VO2 max) measured by exercise tests such as treadmill or
cycle ergometer. CRF is not only a sensitive and reliable mea-
sure of habitual physical activity (American College of Sports
Medicine, 1998; Church et al., 2007; Jackson et al., 2009;
Wang et al., 2010), but also a relatively low-cost and useful
health indicator for both symptomatic and asymptomatic
patients in clinical practice (Gibbons et al., 2002; Gulati
et al., 2005; Myers et al., 2002). According to a recent
World Health Organization (WHO) report, high blood pres-
sure, tobacco use, high blood glucose, physical inactivity, and
obesity (in that order) explain 38% of total global deaths
(WHO, 2009). The American Heart Association (AHA)
stated that ideal cardiovascular disease (CVD) health, a
newly deﬁned concept, comprises of four health behaviors
(non-smoking, body mass index [BMI] <25kg/m
2, physical
activity at goal levels, and pursuit of a recommended diet)
and three health factors (untreated total cholesterol
<200mg/dL, untreated blood pressure <120/80mmHg, and
fasting blood glucose <100mg/dL) (Lloyd-Jones et al., 2010).
Scientiﬁc evidence shows that such behaviors and factors
reported by the WHO and AHA are directly or indirectly
associated with CRF (American College of Sports
Medicine, 1998; Fletcher et al., 2001; Jackson et al., 2009;
Wang et al., 2010).
Although there is convincing evidence that CRF is associ-
ated with morbidity and mortality in both men and women
independently of other risk factors (Carnethon et al., 2003;
Chase et al., 2009; Kodama et al., 2009; Lee et al., 2009b), the
importance of CRF is still often ignored from a clinical per-
spective compared with other risk factors such as smoking,
obesity, high blood pressure, or high blood glucose. In this
review, we provide recent evidence from prospective studies
testing the hypothesis that risks of all-cause and CVD mor-
tality are diﬀerent between diﬀerent levels of baseline CRF
and change in CRF over time. Also, we address the contro-
versial issue of the relative contributions of CRF and obesity
with mortality, and possible mechanisms linking CRF with
mortality risk. Finally we describe the measurement issue of
CRF in clinical settings and the major determinants of CRF.
This review on CRF with mortality may be important in
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Cardiorespiratory fitness and mortality
There is convincing evidence that a moderate or high level of
CRF reduces the risk of all-cause and CVD mortality in both
men and women (Blair et al., 1989; Gulati et al., 2005;
Kokkinos et al., 2008; Mora et al., 2003; Myers et al., 2002;
Sandvik et al., 1993). The protective eﬀect of CRF on mor-
tality is independent of age, ethnicity, adiposity, smoking
status, alcohol intake, and health conditions.
In the Aerobics Center Longitudinal Study (ACLS), com-
pared with the least ﬁt men and women, the most ﬁt men and
women had 43% and 53% lower risk for all-cause mortality,
and 47% and 70% lower risk of CVD mortality, respectively
(Figure 1). The total duration of the maximal treadmill test
used in the CRF classiﬁcation is highly correlated with mea-
sured maximal oxygen uptake (r 0.92) in men (Pollock
et al., 1976) and women (Pollock et al., 1982). Recently, the
ﬁrst meta-analysis has been published on the association of
CRF with all-cause mortality and CVD events (including
fatal and nonfatal CVD) in healthy individuals (Kodama
et al., 2009). This review selected 33 studies comprising
102,980 participants with 6910 all-cause deaths, and 84,323
participants with 4485 CVD events in men and women.
In dose–response analyses, each 1-MET increment in CRF
(corresponding to approximately 1km/h higher running/jog-
ging speed) was associated with a 13% and 15% risk reduc-
tion from all-cause mortality and CVD events, respectively.
P for trend <0.001 in men
and <0.001 in women
P for trend <0.001 in men
and <0.005 in women
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Figure 1. Relative risks of (A) all-cause and (B) cardiovascular disease (CVD) mortality by cardiorespiratory fitness quintiles for 40,451 (2657 all-cause
and 943 CVD deaths) men and 12,831 (375 all-cause and 90 CVD deaths) women aged 20–100 years without CVD or cancer in the Aerobics Center
Longitudinal Study. Cardiorespiratory fitness is measured by total duration during a maximal treadmill exercise test. Relative risks (95% confidence
intervals) are shown inside the bars and adjusted for age, year of examination, body mass index, smoking status, abnormal electrocardiogram,
hypertension, diabetes, hypercholesterolemia, and family history of CVD.
28 Journal of Psychopharmacology 24(11)The authors explained that a 1-MET higher level of CRF is
comparable to a 7-cm, 5-mmHg, 1-mmol/L (88mg/dL), and
1-mmol/L (18mg/dL) decrement in waist circumference, sys-
tolic blood pressure, triglyceride level (in men), and fasting
plasma glucose, respectively, and a 0.2-mmol/L (8mg/dL)
increment in high-density lipoprotein cholesterol based on
other studies (Coutinho et al., 1999; de Koning et al., 2007;
Gordon et al., 1989; Hokanson and Austin, 1996; Lewington
et al., 2002). In addition, individuals with low CRF had a
substantially higher risk of all-cause mortality and CVD
events compared with individuals with moderate and high
CRF after adjustment for heterogeneity of study characteris-
tics. Low CRF values for men and women are approximately
9 and 7 METs in those 40 years old, 8 and 6 METs in 50 years
old, and 7 and 5 METs in 60 years or older, respectively. Data
from the ACLS also supported similar MET values for
low CRF level as a mortality predictor in each age group
(Blair et al., 1995).
Kodama et al. conducted stratiﬁed analyses by some
selected confounders in their review (Kodama et al.,
2009). The risk reduction for all-cause mortality and CVD
events per 1-MET increment in CRF was consistently signif-
icant, regardless of age, sex, smoking, coronary risk factors,
abnormal exercise electrocardiogram, follow-up period,
instrument for assessing CRF, and exercise testing method.
Although a publication bias was suggested by statistical
assessment in this review, adjustment for this bias did not
change the general ﬁndings. Based on the above review, we
believe that CRF is a strong independent predictor of all-
cause mortality and CVD morbidity and mortality.
Therefore, along with other well-established mortality risk
factors such as smoking, obesity, hypertension, and diabetes,
including CRF in risk stratiﬁcation is recommended.
Clinicians should act on this information to promote regular
physical activity in order to reduce premature deaths from
CVD and all causes.
Change in cardiorespiratory fitness
and mortality
Most studies use a single baseline CRF measurement with
subsequent mortality follow-up. However, individual levels
of ﬁtness may change over time due to changes in physical
activity habits or other factors. Two prospective studies in
men have shown an inverse association between change
in CRF and mortality risk. We followed 9777 men (aged
20–82 at baseline) who had two CRF assessments over an
average period of 4.9 years between examinations. These
men were then followed an average of 5.1 years for mortality
to test the hypothesis that change in CRF produce change in
mortality risk. Men who were unﬁt at both visits had the
highest death risk, men who were ﬁt at both visits had the
lowest death risk, and men who changed ﬁtness status had
intermediate risks (Figure 2) (Blair et al., 1995). Unﬁt was
deﬁned as quintile 1 and ﬁt was deﬁned as quintiles 2–5 of
age-speciﬁc maximal exercise duration based on the measure-
ments from the ﬁrst examination. Investigators from Norway
followed 2014 healthy men (aged 40–60 at baseline) and
reported that improvements in CRF within 7 years were asso-
ciated with a signiﬁcantly lower risk of all-cause mortality
during up to 15 years of follow-up, irrespective of CRF
level at baseline. Changes in body weight over time had no
eﬀect on these results (Erikssen et al., 1998).
Health status at baseline may have an inﬂuence on the
association between CRF change and mortality, and worsen-
ing health status at follow-up examinations may lead to early
deaths irrespective of CRF change. Therefore, it is important
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Figure 2. Age-adjusted relative risks of all-cause and cardiovascular disease (CVD) mortality by change in cardiorespiratory fitness for 9777 (223 all-
cause and 87 CVD deaths) men aged 20–82 in the Aerobics Center Longitudinal Study. Cardiorespiratory fitness is measured by total duration during a
maximal treadmill exercise test. Unfit is defined as quintile 1 (20%) and fit is defined as quintiles 2–5 (80%) of age-specific maximal exercise duration.
Relative risks (95% confidence intervals) are shown inside the bars. (Adapted from Blair et al. (1995)).
Lee et al. 29to control the eﬀects of disease conditions at each examina-
tion if possible. Controlling disease conditions can be per-
formed by adjusting for them in multivariable modeling,
conducting stratiﬁed analyses in categories of the disease, or
excluding those unhealthy individuals from the analysis. Both
studies mentioned here used at least one of these approaches
and found that the ﬁndings were unlikely to be biased by
underlying disease.
These two studies on change in CRF and mortality pro-
vide evidence that improvement in CRF is associated with
lower risk of all-cause and CVD death in men. To the best
of the authors’ knowledge, currently no studies have been
conducted in women on CRF change and mortality. Future
studies in women are warranted to determine whether the
ﬁndings in men can be replicated in women.
Cardiorespiratory fitness, obesity,
and mortality
Approximately two-thirds of Americans are overweight or
obese (Flegal et al., 2010) and obesity is the ﬁfth leading
cause of global mortality (WHO, 2009). CRF is a strong
and independent predictor of all-cause and CVD mortality
(Blair et al., 1995; Wei et al., 1999) and physical inactivity
ranks fourth on the WHO list of causes of death (WHO,
2009). Given the diﬃculties of losing weight and maintaining
a reduced weight over the long term (Hainer et al., 2008;
Wing and Phelan, 2005), it is important to identify methods
other than weight loss for risk reduction among obese indi-
viduals. Thus, studying the independent and combined eﬀects
of CRF and obesity with mortality may indicate beneﬁts for
those who are obese and at increased risk for obesity-related
complications such as hypertension, diabetes, or CVD, lead-
ing to early death.
The relative contributions of CRF and obesity to health
outcomes are controversial (Fogelholm, 2010; Lee et al.,
2009a). We have found that a moderate to high level of
CRF eliminates the higher risk of mortality associated with
obesity (Lee et al., 1999). We observed similar ﬁndings among
older adults aged 60 years or older (Sui et al., 2007). In these
ACLS studies, obese individuals (BMI  30) who were ﬁt had
comparable mortality risk to normal-weight individuals who
were unﬁt. These ﬁndings were consistent when using percent-
age body fat or waist circumference instead of BMI. Recently,
the Veterans Exercise Testing Study in men aged 40–70 years
also found that overweight and obese men had higher risk
of all-cause mortality only if they had a low ﬁtness level
(McAuley et al., 2010).
In contrast, Stevens et al. report that both CRF and
obesity are independent predictors of mortality in the
Lipid Research Clinics (LRC) study. High ﬁtness substan-
tially ameliorated the risk of obesity, but did not eliminate
it (Stevens et al., 2002). Another study from the same
research group on the associations of ﬁtness and fatness
with mortality reported that both ﬁtness and fatness had sim-
ilar associations with all-cause and CVD mortality in
American men (Stevens et al., 2004). Both LRC studies
show that ﬁtness attenuates the detrimental eﬀects of obesity
on mortality.
As we concluded earlier (Lee et al., 2009a), there is cur-
rently no consensus on whether CRF eliminates the higher
risk of obesity for mortality. It does seem likely that individ-
uals can reduce their risk of mortality by improving CRF,
regardless of their level of adiposity. The highest risk of mor-
tality is observed in those who are both obese and unﬁt, there-
fore, health professionals should encourage these patients
to engage in regular physical activity to develop and maintain
CRF, whether or not it makes them thin.
Mechanisms linking cardiorespiratory
fitness with mortality
There are several possible biological mechanisms for the risk
reduction of all-cause and CVD mortality in individuals with
higher CRF. CRF improves insulin sensitivity, blood lipid
and lipoprotein proﬁle, body composition, inﬂammation,
and blood pressure and the autonomic nervous system.
Insulin resistance is a major determinant of CVD, especially
in overweight or obese individuals (Reaven, 2005). Emerging
evidence suggests that CRF plays an important role in rela-
tion to insulin resistance and sensitivity. In a large cross-
sectional study, lower CRF was correlated with impaired
insulin sensitivity measured by homeostasis model assessment
of insulin resistance (HOMA-IR) (Leite et al., 2009). There
are similar ﬁndings in older adults (Racette et al., 2006), post-
menopausal women (Messier et al., 2008), and youths (Lee
et al., 2006). Most of these studies also indicate that adiposity
is another key factor on insulin sensitivity. Some (Lee et al.,
2006; Messier et al., 2008), but not all (Leite et al., 2009;
Nyholm et al., 2004; Racette et al., 2006), indicate that the
eﬀects of CRF on insulin sensitivity are attenuated after con-
trolling for adiposity, suggesting that the reduction in insulin
resistance from higher CRF may be partly mediated through
adiposity. However, the relative contributions of adiposity
and CRF to insulin sensitivity are still inconclusive. Because
most of the evidence is based on cross-sectional analyses,
well-conducted prospective studies and randomized con-
trolled trials are needed.
Lipid and lipoprotein concentrations are accepted inde-
pendent risk factors for coronary heart disease (CHD)
(National Cholesterol Education Program Expert Panel on
Detection, 2002). In a cross-sectional study of healthy men
without diabetes, those with low CRF, in comparison with
those with high CRF, had higher triglyceride, apolipoprotein
B (a strong predictor of CHD events), and total cholesterol–
HDL cholesterol ratio after matching individuals with similar
BMI (Arsenault et al., 2007). There are similar ﬁndings from
another cross-sectional study of 297 healthy men, for a given
level of waist circumference, visceral fat, or subcutaneous fat
(Lee et al., 2005). A recent randomized controlled trial of
217 men and women with exercise training and dietary
instruction evaluated associations among lifestyle improve-
ments, in particular increased CRF, and changes in the
blood lipid proﬁle (Kawano et al., 2009). When all partici-
pants were divided into three subgroups according to the
degree of improvement in CRF, apolipoprotein B decreased
and LDL cholesterol–apolipoprotein B ratio increased as
CRF increased. In 127 middle-aged Finnish men, plasma
30 Journal of Psychopharmacology 24(11)saturated fatty acids (positively correlated with triglyceride
and insulin concentration) were lower and polyunsaturated
fatty acids (negatively correlated with triglyceride) were
higher in the most-ﬁt tertile compared with those in the
least-ﬁt tertile (Konig et al., 2003).
Obesity is the ﬁfth leading global risk factor for mortality
(WHO, 2009), and decreased muscle mass and excess adipos-
ity, especially visceral adiposity, are independently related to
mortality (Taylor et al., 2010; Wannamethee et al., 2007).
Two cross-sectional studies revealed that ﬁt men had lower
visceral adipose tissue compared with unﬁt men for a given
BMI, suggesting that the eﬀect of CRF to ameliorate the
health risks associated with BMI may be, in part, mediated
through a less abdominal adiposity (Arsenault et al., 2007;
Wong et al., 2004). In a longitudinal study, higher CRF at
baseline resulted in a lower fat mass gain over 4 years, inde-
pendent of change in lean tissue mass among overweight
Hispanic boys (Byrd-Williams et al., 2008). Another longitu-
dinal study of 459 adults from the Canadian Physical Activity
Longitudinal Study showed that higher CRF at baseline was
associated with lower future risk of obesity over the 20-year
follow-up period, independent of baseline age, physical activ-
ity, BMI, sex, smoking status, andalcohol consumption (Brien
et al., 2007). There is also evidence that change in CRF is
associated with subsequent change in weight gain. In a
cohort of healthy middle-aged men (n¼4599) and women
(n¼724), each 1 minute improvement in treadmill time
reduced the risk of  5kg gain by 14% in men and by 9% in
women (DiPietro et al., 1998). Thus, CRF appears to be an
important predictor of future adiposity, weight gain, and
obesity.
Several population-based cross-sectional studies have
found an inverse association between CRF and C-reactive
protein, an inﬂammatory marker as a predictor of CVD
(Aronson et al., 2004; Church et al., 2002a; Kuo et al.,
2007; Williams et al., 2005). This inverse association was
seen in both men and women and held after controlling for
BMI and other CVD risk factors. Another study also showed
similar results for the association of other inﬂammatory mar-
kers, plasma ﬁbrinogen, white blood cell count, and uric acid,
with CRF (Church et al., 2002b). In addition, these results are
consistent within strata of body composition assessed by
BMI, percentage body fat, or waist circumference. Thus,
CRF may partly decrease the risk of all-cause and CVD mor-
tality through less inﬂammation, regardless of body compo-
sition. High blood pressure is a strong predictor of CVD
events and the number one global risk factor for mortality
responsible for nearly 13% of total deaths in the world
(WHO, 2009). Two large prospective studies, the ACLS and
the Coronary Artery Risk Development in Young Adults
(CARDIA) study, have shown a signiﬁcant inverse associa-
tion between CRF and incident hypertension in both men and
women after adjustment for potential confounders including
BMI (Barlow et al., 2006; Carnethon et al., 2003; Chase et al.,
2009). Some studies found that ﬁt individuals had enhanced
cardiac autonomic nervous system activity as assessed by
analysis of heart rate variability, compared with unﬁt individ-
uals (Buchheit and Gindre, 2006; Ueno et al., 2002). Higher
epicardial fat thickness (measured by echocardiography), an
index of cardiac adiposity that may aﬀect autonomic nervous
system, is associated with poor CRF independent of body
weight in overweight or obese men (Kim et al., 2010).
Increasing evidence suggests that oxidative stress may play
an important role in hypertension (de Champlain et al.,
2004). Another recent study reported a negative association
between CRF and oxidative stress and positive association
between CRF and antioxidant enzyme activity, demonstrat-
ing that CRF may mediate against oxidative stress by
maintaining antioxidant enzyme eﬃciency (Pialoux et al.,
2009).
A cluster of several metabolic factors associated with
higher risk of diabetes, CVD, and all-cause mortality (Gami
et al., 2007; Ford, 2005) may explain an additional proportion
of the mechanisms linking CRF to risk of mortality. Several
reports demonstrate an inverse association between CRF and
risk of developing metabolic syndrome (Hassinen et al., 2008;
Janssen and Cramp, 2007; LaMonte et al., 2005). In a ran-
domized controlled trial of 365 men and women from the
ProActive study, increased CRF was associated with reduced
clustered metabolic risk variables (waist circumference, fast-
ing triacylglycerol, insulin and glucose, blood pressure, and
HDL-cholesterol) over 1-year follow-up, independent of age,
sex, smoking status, socioeconomic status, and baseline met-
abolic score (Simmons et al., 2008).
Assessment of cardiorespiratory fitness
CRF can be measured directly from expired gas analysis or
estimated through various maximal or submaximal exercise
tests generally using a treadmill or cycle ergometer. Because
directly measured CRF (VO2 max) is more precise than other
methods, it is recommended for most research studies. CRF is
typically expressed as multiples of resting metabolic rate
(METs), where a score of 10 METs indicates that a person
can increase resting metabolism 10-fold. However, if direct
measurement of CRF is not feasible due to cost, space, or
equipment, CRF can be estimated from heart rate or exercise
time to exhaustion in various exercise tests. Submaximal exer-
cise tests are less diﬃcult and more convenient in terms of
time, eﬀort, and cost, yet still provide adequate estimates of
CRF. A review study indicates that submaximal testing
appears to have greater applicability with high correlation
between maximal and submaximal testing (r¼0.7–0.9) in var-
ious submaximal tests such as submaximal treadmill and cycle
ergometer tests, 12-minute run test, and 1-mile walk test
(Noonan and Dean, 2000). The American College of Sports
Medicine provides guidelines for exercise testing including
various test modes and protocols, general procedures, test
termination criteria, and normative values for CRF by sex
and age (American College of Sports Medicine, 2009). The
American Heart Association also provides recommendations
for clinical exercise testing laboratories (Fletcher et al., 2001;
Myers et al., 2009), and a scientiﬁc statement highlighting the
major clinical and research applications of CRF assessment
(Arena et al., 2007).
Although exercise testing is generally safe, major compli-
cations such as myocardial infarction or serious arrhythmias
have been reported at a rate of up to 5 per 10,000 tests,
and sudden cardiac death has occurred in up to 0.5 per
10,000 tests (Arena et al., 2007; Gordon and Kohl, 1993).
Lee et al. 31The American College of Cardiology/American Heart
Association provides guidelines for exercise testing in patients
with known or suspected CVD (Gibbons et al., 1997, 2002).
The terms CRF and physical activity are sometimes used
interchangeably. However, physical activity is self-reported in
many studies and is subject to major misclassiﬁcation (Walsh
et al., 2004), leading to underestimation of the association
between physical activity and health outcomes. We recently
reported that CRF is more strongly associated with all-cause
mortality than self-reported physical activity in 42,373 men
and women (Lee et al., 2010). Therefore, using objectively
measured CRF rather than self-reported physical activity
may provide less biased data on the association between
habitual physical activity and risk of mortality.
Many reports have recommended that CRF assessment
should be included in the clinical setting based on the impor-
tance of CRF to morbidity and mortality prevention
(Gibbons et al., 2002; Gulati et al., 2005; Kodama et al.,
2009; Myers et al., 2002). CRF is recognized as a stronger
predictor of mortality than established risk factors such
as hypertension, smoking, and diabetes in both healthy indi-
viduals and those with CVD (Myers et al., 2002). In addition,
each 1 MET increase in CRF change was associated with a
reduction of approximately 16% in mortality risk (Blair et al.,
1995).
We believe clinicians should also use CRF from routine
exercise test to stratify risk, classify patients, and make
clinical recommendations providing important additional
information.
Determinants of cardiorespiratory fitness
CRF is a surrogate measure of functional status of respira-
tory, cardiovascular, and skeletal muscle systems. Individual
level of CRF depends on those modiﬁable (physical activity,
smoking, obesity, and medical condition) and non-modiﬁable
(age, gender, and genotype) factors, but is primarily deter-
mined by physical activity (Table 1). After reaching the max-
imal value of CRF between age of 20–30 years, CRF starts to
decline with age and the rate of decline accelerates markedly
with advancing age in healthy populations according to two
longitudinal studies (Fleg et al., 2005; Jackson et al., 2009).
In these studies, the pattern of decline with age is accelerated
by reducing physical activity and weight gain.
Women have approximately 2 METs lower CRF capacity
than men, attributed to their smaller muscle mass, lower
hemoglobin and blood volume, and smaller stroke volume
compared with men (Fletcher et al., 2001). Based on the US
National Health and Nutrition Examination Surveys, the
estimated mean CRF level was 12 METs for men and 10
METs for women aged 20–49 years (Wang et al., 2010).
Genetic factors may also contribute to individual variation
in CRF level. The most well-known ﬁndings on the role of
genotype in CRF were derived from the HERITAGE Family
Study in more than 700 healthy but sedentary men and
women (Bouchard et al., 1999; Bouchard and Rankinen,
2001; Rankinen et al., 2010). After 20 weeks of exercise train-
ing, although the mean CRF increased approximately
15–18% in all four sex and generation groups (fathers,
mothers, sons, and daughters), there was 2.5 times more var-
iance between families than within families in the CRF
response, and the maximal heritability estimate of the CRF
response to training reached 47%. Although little is known
about the role of speciﬁc genes on CRF, familial and genetic
factors clearly contribute to CRF.
Medical conditions related to respiratory, cardiovascular,
or skeletal muscle function can have an inﬂuence on CRF.
Data from several studies show that average METs in indi-
viduals with CVD, diabetes, or hypertension are roughly
10–25% lower than those in relatively healthy individuals
(Blair et al., 1995; Gulati et al., 2005; Myers et al., 2002). In
a cross-sectional US national data study, hypertension,
hypercholesterolemia, and low HDL-cholesterol levels were
more prevalent among adults with low CRF compared with
individuals with moderate or high CRF (Carnethon et al.,
2005).
Among lifestyle factors, physical activity is a principal
determinant of CRF (American College of Sports Medicine,
1998; Physical Activity Guidelines Advisory Committee,
2008). Evidence from randomized controlled trials demon-
strate a dose–response relationship between physical activity
and improvement in CRF, suggesting that increasing either
intensity or volume of physical activity appears to have addi-
tional eﬀects on CRF after controlling for each other (Church
et al., 2007; Duscha et al., 2005; O’Donovan et al., 2005), as
seen in Figure 3. Even moderate intensity physical activity at
40–55% of peak VO2 intensity is suﬃcient to improve CRF
(Church et al., 2007; Duscha et al., 2005). Also, ﬁndings from
the prospective studies on CRF change and mortality showed
that men who improved CRF increased their physical activity
over the same period (Blair et al., 1995; Erikssen et al., 1998).
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Figure 3. Change in cardiorespiratory fitness (CRF) by physical activity.
(Adapted from Physical Activity Guidelines Advisory Committee (2008)).
Table 1. Determinants of cardiorespiratory fitness
Non-modifiable Modifiable
Age Physical activity
Gender Smoking
Genotype Obesity
Medical condition
32 Journal of Psychopharmacology 24(11)In addition to regular physical activity, the US national
survey indicated that individuals who were obese had approx-
imately 10–15% lower CRF than non-obese individuals
(Wang et al., 2010). Recent ﬁndings from the ACLS show
that engaging in physical activity, maintaining a normal
weight, and not smoking were associated with substantially
higher levels of CRF across the adult life span in both men
and women (Jackson et al., 2009).
Conclusion
Moderate to high levels of CRF and improvement in CRF are
associated with a lower risk of mortality from all-causes and
CVD in both men and women regardless of age, smoking
status, body composition, other risk factors, method of
CRF assessment, and study design. CRF appears to attenuate
the higher risk of death associated with obesity although it is
not yet clear whether CRF completely eliminates mortality
risk in obese individuals. We believe that including CRF in
clinical examinations along with traditional evaluations
such as blood pressure measurement and blood chemistry
analyses may contribute to chronic disease prevention and
longer life span.
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